HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.32
-0.41 (-2.78%)
Nov 17, 2026, 10:17 AM EST - Market open
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.48 billion as of November 17, 2026. Its market cap has decreased by 5.53% in one year.
Market Cap
2.48B
Enterprise Value
1.22B
1-Year Change
-5.53%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.48B, an increase of 55.59%. That is a compound annual growth rate of 4.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 2.48B | 6.88% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 3.89B |
| Bausch Health Companies | 3.13B |
| Xeris Biopharma Holdings | 3.04B |
| Regencell Bioscience Holdings | 2.45B |
| Perrigo Company | 2.25B |
| Prestige Consumer Healthcare | 2.19B |
| Trulieve Cannabis | 2.10B |
| BioCryst Pharmaceuticals | 1.96B |